1 min to read News Posted on January 28, 2023 London-listed SPAC targets merger with chronic disease drug developer Istesso – Yahoo Eurosport UK London-listed SPAC targets merger with chronic disease drug developer Istesso Yahoo Eurosport UK Source: London-listed SPAC targets merger with chronic disease drug developer Istesso – Yahoo Eurosport UK share tweet share By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawSPAC Promoters Lost $1B+ in 2022, and There’s More Pain to Come – 24/7 Wall St.Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPACSPACs: Are You Really Ready To Commit? Tags: SPACs